Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0002034668-25-000010

Chief Financial Officer sold 18,400 shares at an average $18.54 ($341,074)

  • Chief Financial Officer acquired 18,400 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hyep Ivan · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-21 Exercise or conversion : show line 1 in the form 10b5-1 +605 $3.79 $2,293 145,960 D
2025-11-21 Sale : show line 2 in the form 10b5-1 −605 $18.15 $10,981 145,355 D
2025-11-24 Exercise or conversion : show line 3 in the form 10b5-1 +17,795 $3.79 $67,439 163,150 D
2025-11-24 Sale : show line 4 in the form 10b5-1 −17,795 $18.55 $330,094 145,355 D
Open-market sales · 18,400 sh · avg $18.54 · $341,074

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-11-21 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −605 115,979 D
2025-11-24 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −17,795 98,184 D
Loading xslF345X05/wk-form4_1764114131.xml…